DRKS00012688尚未招募未知
Identifying the minimal dose and optimal combination of high-intensity aerobic interval training (HIIT) and strength training to improve physical fitness and cardiometabolic risk markers in sedentary adults – a randomized-controlled pilot and feasibility study - LOWHIIT
niversitätsklinikum Mannheim0 个研究点目标入组 40 人开始时间: 2017年8月2日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 25 Years 至 50 Years（—）
- 性别
- All
入选标准
- •Sedentary Lifestyle, no regular physical exercise
排除标准
- •Kardiovascular disease, tumor, dementia, psychosis, severe musclulosceletal disorder
研究者
相似试验
招募中
2 期
Two Combination Treatment Regimens of Nivolumab and Ipilimumab in Patients With dMMR and / or MSI mCRC. (NIPISAFE)2024-518138-10-00Association Gercor93
已完成
不适用
Dose finding for a safe and efficacious combination of chloroquine (CQ) and methylene blue in the treatment of uncomplicated falciparum malaria in young children of Burkina Fasoncomplicated falciparum malariaInfections and InfestationsMalariaISRCTN36731786DSM Fine Chemicals (Austria)576
撤回
不适用
Determination of Minimum and Non-provoking Doses of Soy Protein in Soy Allergic Individualsfood allergysoy allergy10001708NL-OMON34810FARRP: Food Allergy Research and Resource Program5
已完成
不适用
Determination of minimum and non-provoking doses of soy protein in soy allergic individualssoy allergy10001708food allergyNL-OMON39595FARRP; Food Allergy Research and Resource Program, Department of Food Science & Technology, University of Nebraska10
招募中
不适用
Investigation of the maximum optimal dosage and efficacy of lenalidomide for the treatment of relapsed and refractory multiple myeloma.multiple myelomaJPRN-UMIN000010178Kurume University Hospital Division of Hematology and Oncology38